Efficacy and safety of baricitinib for the treatment of hospitalised adults with COVID-19 (COV-BARRIER): a randomised, double-blind, parallel-group, placebo-controlled phase 3 trial
収録刊行物
-
- The Lancet Respiratory Medicine
-
The Lancet Respiratory Medicine 9 (12), 1407-1418, 2021-12
Elsevier BV